2026-526096-31-00CompletedPhase 1
A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 May 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 27 Mar 2026
- Start date
- 20 May 2026
- Lead sponsor
- Corteria Pharmaceuticals
- EU CT number
- 2026-526096-31-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 20
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pharmaceutical Research Associates Group B.V. | Groningen | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.